Amphivena Therapeutics
Amphivena Therapeutics is a bi-functional antibody therapy founded in 2012.
2
Funding Rounds
$76.0m
Money raised
Overview
Amphivena Therapeutics is a bi-functional antibody therapy founded in 2012.
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Amphivena Therapeutics has raised a total of $14m in funding over 2 rounds.
Key Insights:
- AmphivenaTherapeutics Series A round: $14m
- Amphivena Therapeutics Inc funding round, September 2019: $62m
AmphivenaTherapeutics Series A round
$14m
Amphivena Therapeutics Inc funding round, September 2019
$62m
Industries
Amphivena Therapeutics is active in the following industries:
- Biopharmaceutical
- Immunotherapy
- Engineering
- Biomedical engineering